Evidence map›Paper›PMID 42679933›Full record

ArticleNeurobiology of disease2026

Parkinson's disease-linked D620N mutation selectively alters the brain-specific protein interactome of VPS35.

Erin T Williams, Maxwell Frye, Xi Chen, Jordan Rowlands, Md Shariful Islam, Darren J Moore

Abstract read
In one paragraph

Article in Neurobiology of disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Erin T WilliamsDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA; West Michigan Neurodegenerative Diseases (MiND) Program, Van Andel Institute, Grand Rapids, MI 49503, USA.
Maxwell FryeWest Michigan Neurodegenerative Diseases (MiND) Program, Van Andel Institute, Grand Rapids, MI 49503, USA.
Xi ChenDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA.
Jordan RowlandsDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA.
Md Shariful IslamDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA.
Darren J MooreDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA; West Michigan Neurodegenerative Diseases (MiND) Program, Van Andel Institute, Grand Rapids, MI 49503, USA. Electronic address: darren.moore@vai.org.

Funding

Exploring mechanisms of Parkinson's disease-linked D620N VPS35 in rat modelsR01NS117137 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN · 2020 to 2024
$2.2M
Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's DiseaseR01NS105432 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN · 2017 to 2021
$2.1M
NINDS NIH HHS R01 NS105432NINDS NIH HHS R01 NS117137
6 · The paper itself

Abstract

Mutations in several genes are known to cause familial forms of Parkinson's disease (PD), including mutations in the vacuolar protein sorting 35 ortholog (VPS35) gene linked to late-onset, autosomal dominant PD. VPS35 encodes a core subunit of the retromer complex which functions in endosomal sorting and recycling. It remains unclear how the pathogenic D620N mutation in VPS35 disrupts retromer function to induce neurodegeneration in PD. Using cell- and rodent-based models expressing D620N VPS35, we performed interactome proteomics to identify alterations underlying the pathogenic effects of D620N VPS35 in PD. Using overexpression of VPS35 variants in HEK-293 T cells, we conducted tandem affinity purification (TAP) or co-immunoprecipitation (co-IP) with protein chemical crosslinking to determine the native and non-native protein interactomes of wild-type (WT) and D620N VPS35, respectively. Notably, we can confirm the reduced interaction of D620N VPS35 with components of the WASH complex. Additionally, using a viral-mediated gene transfer model of human D620N VPS35 overexpression in adult rat brain, we identify the first brain-specific protein interactome of VPS35. These overexpression models reveal remarkably similar interaction profiles of WT and D620N VPS35, suggesting that the D620N mutation has a subtle effect on the overall VPS35 protein interactome. We also conducted proteomic analysis of brain tissue from a D620N VPS35 knockin (KI) mouse model that expresses VPS35 at endogenous levels. Using co-IP from hemibrain or striatal extracts of WT and D620N VPS35 KI mice, we reveal a high degree of similarity between the brain interactomes of WT and D620N VPS35, further suggesting a subtle effect of the D620N mutation on VPS35 protein interactions. Notably, in both hemibrain and striatum, we find a selective decrease in the interaction of two known interactors, TBC1D5 and VPS29, with D620N VPS35. We also performed global proteomic analysis of striatal tissue from D620N VPS35 KI mice and reveal a high degree of similarity between WT and D620N, further suggesting a subtle effect of this mutation. Together, our study provides a comprehensive evaluation of the VPS35 protein interactome and reveals a selective effect of the PD-linked D620N mutation in mammalian cells and brain. Our study provides key insight into the mechanisms of retromer dysfunction in VPS35-linked PD.

Indexed as

BrainParkinson DiseaseVesicular Transport ProteinsAnimalsHEK293 CellsHumansMaleMiceMice, TransgenicMutationProteomicsRatsVesicular Transport ProteinsVPS35 protein, humanVps35 protein, mouseInteractomeParkinson's diseaseProteomicsRetromerVPS35

Identifiers

PMID42679933
PMCPMC13637964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.